<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01237925</url>
  </required_header>
  <id_info>
    <org_study_id>ERE 185v2-10</org_study_id>
    <nct_id>NCT01237925</nct_id>
  </id_info>
  <brief_title>Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Gel) in the Relief of Sunburn Related Symptoms</brief_title>
  <official_title>Non-inferiority, Monocentric Comparative Open Study of Two Topical Pharmaceutical Preparations (Cream and Gel) of Dexchlorpheniramine Maleate in the Evaluation of Safety and Efficacy for the Relief of Mild to Moderate Sunburn Related Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mantecorp Industria Quimica e Farmaceutica Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mantecorp Industria Quimica e Farmaceutica Ltd.</source>
  <brief_summary>
    <textblock>
      Topical antihistamines can be used to promote relief of sunburn related symptoms (erythema,
      itch and burning sensations). Dexchlorpheniramine maleate 1% cream is a topical antihistamine
      formulation approved by ANVISA in Brazil for the relief of skin irritation and pruritus,
      including the ones caused by sunburn. The aim of the present study is to demonstrate
      non-inferiority of a new pharmacological preparation of dexchlorpheniramine maleate (1% gel)
      with the standard preparation (1% cream) for the relief of sunburn related symptoms and to
      demonstrate the safety of both preparations.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pruritus intensity evaluated with a 10-point Visual Analogic Scale (VAS)</measure>
    <time_frame>7 days</time_frame>
    <description>The evaluation of the pruritus will be made by a 10-point visual analog scale, answered by patients at each visit. The sum of weighted scores will be calculated for each sign / symptom in each patient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite clinical evaluation of erythema, pruritus and burning sensation performed by the investigator using a 4-point scale for each one of the variables (absent, mild, moderate, intense).</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Sunburn</condition>
  <arm_group>
    <arm_group_label>Dexchlorpheniramine 1% gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexchlorpheniramine 1% cream</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexchlorpheniramine 1% gel</intervention_name>
    <description>Small amount applied over the lesion twice a day for 7 days</description>
    <arm_group_label>Dexchlorpheniramine 1% gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexchlorpheniramine 1% cream</intervention_name>
    <description>Small amount applied over the lesion twice a day for 7 days</description>
    <arm_group_label>Dexchlorpheniramine 1% cream</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signs of solar erythema of mild to moderate intensity resulting from voluntary
             exposure to sun within the last 72 hours

          -  Compliance of the subject to the treatment protocol

          -  Agreement with the terms of the informed consent by the participants or their legal
             guardians when younger than 18 years old

        Exclusion Criteria:

          -  Pregnancy or risk of pregnancy

          -  Lactation

          -  Signs of severe sunburn (vesicles, bullae or ulceration)

          -  Use of topical or systemic anti-inflammatory, antihistamine or immunosuppressive drugs
             within the last 48 hours prior to the study

          -  History of atopy or allergic diseases

          -  History of allergy to any component of the formulations

          -  Other conditions considered by the investigator as reasonable for non-eligibility
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sérgio Schalka, M.D.</last_name>
    <phone>+551136811334</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Medcin Instituto da Pele Ltda</name>
      <address>
        <city>Osasco</city>
        <state>São Paulo</state>
        <zip>06023-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sérgio Schalka, M.D.</last_name>
      <phone>+551136811334</phone>
    </contact>
    <investigator>
      <last_name>Patrícia C. Pinto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2010</study_first_posted>
  <last_update_submitted>November 8, 2010</last_update_submitted>
  <last_update_submitted_qc>November 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Celso Pereira Sustovich</name_title>
    <organization>Mantecorp Industria Quimica e Farmaceutica Ltd.</organization>
  </responsible_party>
  <keyword>Sunburn</keyword>
  <keyword>Dexchlorpheniramine</keyword>
  <keyword>Gel</keyword>
  <keyword>Cream</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sunburn</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexchlorpheniramine</mesh_term>
    <mesh_term>Chlorpheniramine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

